Mpox (Affenpocken)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 368.17 billion USD, with a 24h change of +1.22%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is GeoVax Labs, Inc. New (GOVX), with a 24h increase of +3.05%.Modest rebound with weak breadth and narrow leadership. Near term, follow liquid leaders; longer term, prioritize clinical/regulatory milestones, balance-sheet strength, and rate sensitivity.
Name
Letzter Preis
Änderung %
Letzter Preis / Änderung %
Chart
Price Range
Aktion
ABT
ABTAbbott Laboratories
104,58$104,49
+1,43 %
-0,08 %
AH
104,58
+1,43 %
$104,06$105,72
GILD
GILDGilead Sciences Inc
130,49$130,58
+0,89 %
+0,06 %
AH
130,49
+0,89 %
$130,49$132,51
DGX
DGXQuest Diagnostics Inc.
231,90$231,84
+1,77 %
-0,02 %
AH
231,90
+1,77 %
$228,02$231,90
CODX
CODXCo-Diagnostics, Inc.
2,03$2,04
-3,33 %
+0,49 %
AH
2,03
-3,33 %
$1,95$2,13
GOVX
GOVXGeoVax Labs, Inc. New
0,75$0,79
+3,05 %
+5,91 %
AH
0,75
+3,05 %
$0,72$0,79